ANALYSIS OF THE P53 GENE IN PATIENTS WITH ISOCHROMOSOME-17Q AND PH(1)-POSITIVE OR PH1-NEGATIVE MYELOID-LEUKEMIA

Citation
J. Schutte et al., ANALYSIS OF THE P53 GENE IN PATIENTS WITH ISOCHROMOSOME-17Q AND PH(1)-POSITIVE OR PH1-NEGATIVE MYELOID-LEUKEMIA, Leukemia research, 17(6), 1993, pp. 533-539
Citations number
39
Categorie Soggetti
Oncology,Hematology
Journal title
ISSN journal
01452126
Volume
17
Issue
6
Year of publication
1993
Pages
533 - 539
Database
ISI
SICI code
0145-2126(1993)17:6<533:AOTPGI>2.0.ZU;2-M
Abstract
Increased incidence of p53 gene aberrations or chromosome 17p monosomy resulting from an isochromosome 17q [i(17q)] has been observed with t ransition of chronic myelogenous leukemia (CML) to myeloid blast crisi s (BC), and in some patients with poor risk acute myeloid leukemia (AM L) progressing from myelodysplastic syndrome (MDS). These data suggest ed that disease progression may be linked to bi-allelic inactivation o f p53. Here, we report on p53 gene analyses of nine patients with CML- BC and AML who showed an i(17q) as characteristic cytogenetic anomaly. Using Southern blots, agarose gel electrophoresis and single-strand c onformation polymorphism analyses of PCR products from genomic DNA and cDNA, spanning exons 4 through 9, we did not detect any structural ab normalities of the remaining p53 allele. These findings question the h ypothesis that p53 gene alterations are the principal molecular event responsible for progression of CML chronic phase or MDS to i(17q)-posi tive CML-BC or AML, respectively.